awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38697702-37E76FF1-D36A-44A3-B777-96B599730BF6
Q38697702-37E76FF1-D36A-44A3-B777-96B599730BF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38697702-37E76FF1-D36A-44A3-B777-96B599730BF6
The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells.
P2860
Q38697702-37E76FF1-D36A-44A3-B777-96B599730BF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38697702-37E76FF1-D36A-44A3-B777-96B599730BF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
efbf0042e4edabf0262b91e7494d89a35170fc1c
P2860
Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.